Ad is loading...
GPSCX vs VEXRX
GPSCX vs VEXRX Comparison
Open Charts GPSCX vs VEXRX
Victory RS Small Cap Equity A
Price$8.38
Change+$0.21 (+2.57%)
VolumeN/A
Net Assets25.82M
GPSCX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
GPSCX vs. VEXRX commentary
Apr 24, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPSCX is a StrongBuy and VEXRX is a Buy.
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. GPSCX (25.8M). VEXRX pays higher dividends than GPSCX: VEXRX (0.56) vs GPSCX (0.47). GPSCX was incepted earlier than VEXRX: GPSCX (28 years) vs VEXRX (23 years). GPSCX (1.37) is less costly to investors than VEXRX (0.34). GPSCX is a more actively managed with annual turnover of: 192.00 vs. VEXRX (35.00). GPSCX has a lower initial minimum investment than VEXRX: GPSCX (2500) vs VEXRX (50000). GPSCX annual gain was more profitable for investors over the last year : -3.77 vs. VEXRX (-12.82). VEXRX return over 5 years is better than : 15.80 vs. GPSCX (-39.42).
| GPSCX | VEXRX | GPSCX / VEXRX | |
| Total Expense Ratio | 1.10 | 0.34 | 324% |
| Annual Report Gross Expense Ratio | 1.37 | 0.34 | 403% |
| Fund Existence | 28 years | 23 years | - |
| Gain YTD | -18.649 | -14.722 | 127% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 50000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 25.8M | 19.8B | 0% |
| Annual Yield % from dividends | 0.47 | 0.56 | 84% |
| Returns for 1 year | -3.77 | -12.82 | 29% |
| Returns for 3 years | -12.96 | -9.40 | 138% |
| Returns for 5 years | -39.42 | 15.80 | -250% |
| Returns for 10 years | -63.01 | -1.76 | 3,573% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 79.10 | 1.46 | +1.88% |
| SPDR® S&P Biotech ETF | |||
| CHI | 9.78 | 0.17 | +1.77% |
| Calamos Convertible Opportunities and Income Fund | |||
| SBIO | 28.02 | 0.45 | +1.63% |
| ALPS Medical Breakthroughs ETF | |||
| BCDF | 28.54 | 0.12 | +0.44% |
| Horizon Kinetics Blockchain Dev ETF | |||
| FEP | 41.67 | -0.06 | -0.14% |
| First Trust Europe AlphaDEX® ETF | |||